Binding of activation of kinin-forming proteins on vascular endothelial cells

Immunopharmacology

Volumn 36, Issue 2-3, 1997, Pages 201-207

  Kaplan, Allen P ^a,b   Joseph, Kusumam ^a   Shibayama, Yoji ^a,c  

^a STONY BROOK UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Nippon Zoki Pharmaceutical Co   (Japan)

Author keywords

Bradykinin; gC1q R; Kallikrein; Kininogen

Indexed keywords

BINDING PROTEIN; BLOOD CLOTTING FACTOR 12; BRADYKININ; COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; KININ; PREKALLIKREIN; ZINC;

BLOOD CLOTTING; CELL MEMBRANE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KALLIKREIN KININ SYSTEM; PRIORITY JOURNAL; PROTEIN BINDING; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANTIGENS, CD44; BINDING, COMPETITIVE; BLOOD PROTEINS; CARRIER PROTEINS; CELL MEMBRANE; CELLS, CULTURED; COMPLEMENT C1Q; CYSTEINE PROTEINASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; FACTOR XII; HUMANS; KININOGENS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIAL PROTEINS; MOLECULAR WEIGHT; PREKALLIKREIN; RECEPTORS, COMPLEMENT; RECEPTORS, PEPTIDE; RECOMBINANT PROTEINS; UMBILICAL VEINS; ZINC;

EID: 0030746444     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00022-2     Document Type: Conference Paper

References (39)

1. Berrettini, M., Schleef, R.R., Heeb, M.J., 1992. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells. J. Biol. Chem. 267, 19833-19839.
2. Boon-Leong, L., Preissner, K.T., Ghebrehiwet, B. et al., The binding protein for globular 'heads' of complement C1q, gC1qR. Functional expression and characterization of a novel vitronectin binding factor. J. Biol. Chem., in press.
3. De La Cadena, R.A., Wyshock, E.G., Kunapuli, S.P., 1994. Platelet thrombospondin interactions with human high and low molecular weight kininogens. Thromb. Haemost. 72, 125-131.
4. Dunn, J.T., Silverberg, M., Kaplan, A.P., 1982. The cleavage and formation of activated Hageman factor by autodigestion and by kallikrein. J. Biol. Chem. 275, 1779-1784.
5. Eggleton, P., Ghebrehiwet, B., Sastry, K.N., 1995. Identification of a gC1q-binding protein (gC1qR) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1qR. J. Clin. Invest. 95, 1569-1578.
6. Ghebrehiwet, B., 1989. Functions associated with the C1q receptor. Behring Inst. Mitt. 84, 204.
7. Ghebrehiwet, B., Lim, B.-L., Peerschke, E.I.B., 1994. Isolation, cDNA cloning and overexpression of a 33-kD cell surface glycoprotein that binds to the globular 'heads' of C1q. J. Exp. Med. 179, 1809-1821.
8. Ghebrehiwet, B., Kew, R.R., Gruber, B.L., 1995. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokines. J. Immunol. 155, 2614-2619.
9. Greengard, J.S., Griffin, J.H., 1984. Receptor for high molecular kininogen on stimulated washed human platelets. Biochemistry 23, 6863-6869.
10. Griffin, J.H., Cochrane, C.G., 1976. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc. Natl. Acad. Sci. USA 73, 2554-2558.
11. Griffin, J.H., 1978. Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII). Proc. Natl. Acad. Sci. USA 75, 1998-2002.
12. Gustafson, E.J., Schutsky, D., Knight, L.C., 1986. High molecular weight kininogen binds to unstimulated platelets. J. Clin. Invest. 78, 310-318.
13. Gustafson, E.J., Schmaier, A.H., Wachtfogel, Y.T., 1989. Human neutrophils contain and bind high molecular weight kininogen. J. Clin. Invest. 84, 28-35.
14. Hasan, A.A.K., Cines, D.B., Zhang, J., 1994. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain. J. Biol. Chem. 269, 31822-31830.
15. Hasan, A.A.K., Cines, D.B., Herwald, H., 1995. Mapping the cell binding site on high molecular weight kininogen domain 5. J. Biol. Chem. 270, 19256-19261.
16. Henderson, L.M., Figueroa, C.D., Muller-Esterl, W., 1994. Assembly of contact phase factors on the surface of the human neutrophil membrane. Blood 84, 474.
17. Herwald, H., Hasan, A.A.K., Gudovac-Zimmerman, S., 1995. Identification of an endothelial cell binding site on kininogen Domain 3. J. Biol. Chem. 270, 14134-14642.
18. Herwald, H., Dedio, J., Kellner, R., 1996. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. J. Biol. Chem. 271, 13040-13047.
19. Jacobsen, S., Kritz, M., 1967. Some data on two purified kininogens from human plasma. Br. J. Pharmacol. 29, 25-36.
20. Joseph, K., Ghebrehiwet, B., Peerschke, E.I.B., 1996. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: Identity with the receptor that binds to the globular 'heads' of C1q (gC1qR). Proc. Natl. Acad. Sci. USA 93, 8552-8557.
21. Mandle, R.J. Jr., Colman, R.W., Kaplan, A.P., 1976. Identification of prekallikrein and HMW-kininogen as a complex in human plasma. Proc. Natl. Acad. Sci. USA 73, 4179-4183.
22. Meier, H.L., Pierce, J.V., Colman, R.W., 1977. Activation and function of human Hageman factor. The role of high molecular kininogen and prekallikrein. J. Clin. Invest. 60, 18-31.
23. Meloni, F.J., Gustafson, E.J., Schmaier, A.H., 1992. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Blood 79, 1233-1244.
24. Peerschke, E.I., Malhotra, R., Ghebrehiwet, B., 1993. Isolation of a human endothelial cell C1q receptor (C1qR). J. Leukocyte Biol. 53, 179-184.
25. Peerschke, E.I.B., Reid, K.B.M., Ghebrehiwet, B., 1994. Identification of a novel 33-kDa C1q-binding site on human blood platelets. J. Immunol. 152, 5896-5901.
26. Peerschke, E.I.B., Smyth, S.S., Teng, E.I., 1996. Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q. J. Immunol. 157, 4154-4158.
27. Pierce, J.V., Webster, M.F., 1961. Biochem. Biophys. Res. Commun. 5, 353-357.
28. Puri, R.N., Zhou, F., Hu, C.-J., 1991. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin the platelets. Blood 77, 500-507.
29. Reddigari, S.R., Kuna, P., Miragliotta, G.F., 1993a. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. Blood 81, 1306-1311.
30. Reddigari, S.R., Shibayama, Y., Brunnee, T., 1993b. Human Hageman factor (FXII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268, 11982-11987.
31. Schmaier, A.H., Kuo, A., Lundberg, D., 1988. The expression of high molecular weight kininogen on human umbilical vein endothelial cells. J. Biol. Chem. 263, 16327-16333.
32. Silverberg, M., Kaplan, A.P., 1982. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII). Blood 60, 64-70.
33. Tait, J.F., Fujikawa, K., 1987. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. J. Biol. Chem. 262, 11651-11656.
34. Tankersley, D.L., Finlayson, J.S., 1984. Kinetics of activation and autoactivation of human factor XII. Biochemistry 23, 273-279.
35. Thompson, R.E., Mandle, R.J. Jr., Kaplan, A.P., 1977. Association of factor XI and high molecular weight kininogen in human plasma. J. Clin. Invest. 60, 1376-1380.
36. Thompson, R.E., Mandle, R.J., Kaplan, A.P., 1978. Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. J. Exp. Med. 147, 488-499.
37. Van Iwaarden, F., deGroot, P.G., Bouma, B.N., 1988. The binding of high molecular weight kininogen to cultured human endothelial cells. J. Biol. Chem. 263, 4698-4703.
38. Wachtfogel, Y.T., De La Cadena, R.A., Kunapuli, S.P., 1994. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J. Biol. Chem. 269, 19307-19312.
39. Wiggins, R.C., Bouma, B.N., Cochrane, C.G., 1977. Role of high molecular weight kininogen in surface-binding and activation of coagulation factor XIa and prekallikrein. Proc. Natl. Acad. Sci. USA 77, 4636-4640.